The role of angiotensin in obesity and metabolic disease

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 11, Issue 3, 2011, Pages 198-205

  Mathai, Michael L ^a   Chen, Nora ^b   Cornall, Lauren ^a   Weisinger, Richard S ^b  

^a VICTORIA UNIVERSITY   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

Angiotensin converting enzyme; Fat metabolism; Glucose metabolism

Indexed keywords

ALISKIREN; ANGIOTENSIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CANDESARTAN; CAPTOPRIL; CARDIOVASCULAR AGENT; ENALAPRIL; GLUCOSE; INSULIN; IRBESARTAN; LEPTIN; PERINDOPRIL; RAS PROTEIN; TELMISARTAN; UNCLASSIFIED DRUG; VALSARTAN; VALSARTAN PLUS TELMISARTAN;

BODY MASS; DRUG INHIBITION; ENERGY EXPENDITURE; GENETICS; GLUCOSE METABOLISM; HEART FAILURE; HUMAN; HYPERTENSION; LEAN BODY WEIGHT; LIPID OXIDATION; LIPOLYSIS; MEDICAL RESEARCH; METABOLIC DISORDER; NONHUMAN; OBESITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

EID: 79961055768     PISSN: 18715303     EISSN: 18715303     Source Type: Journal    
DOI: 10.2174/187153011796429853     Document Type: Review

References (82)

1. Pi-Sunyer, F. X. (1993) Medical hazards of obesity. Ann. Intern. Med., 119, 655-660.
2. Montague, C.T. and O'Rahilly, S., (2000) The perils of portliness: causes and consequences of visceral adiposity. Diabetes, 49, 883-888.
3. Hall, J. E.; da Silva, A. A.; do Carmo, J. M.; Dubinion, J.; Hamza, S.; Munusamy, S.; Smith, G. and Stec, D. E. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J. Biol. Chem., 285, 17271-17276.
4. Unger, R. H. (2003) Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology, 144, 5159-5165.
5. McKinley, M. J.; Badoer, E. and Oldfield, B. J. (1992) Intravenous angiotensin II induces Fos-immunoreactivity in circumventricular organs of the lamina terminalis. Brain Res., 594, 295-300.
6. Thunhorst, R. L.; Lewis, S. J. and Johnson, A. K. (1993b) Role of arteria baroreceptor input on thirst and urinary responses to intracerebroventricular angiotensin II. Am. J. Physiol., 265, R591-R595.
7. Weisinger, R. S.; Blair-West, J. R.; Burns, P.; Denton, D. A.; McKinley, M. J. and Tarjan, E. (1996) The role of angiotensin II in ingestive behaviour: a brief review of angiotensin II, thirst and Na appetite. Regul. Pept., 66, 73-81.
8. Weisinger, R. S.; Blair-West, J. R.; Denton, D. A. and Tarjan, E. (1997) Role of brain angiotensin II in thirst and sodium appetite of sheep. Am. J. Physiol., 273, R187-R196.
9. Fleming, I.; Kohlstedt, K. and Busse, R. (2006) The tissue renin-angiotensin system and intracellular signalling. Curr. Opin. Nephrol. Hypertens., 15, 8-13.
10. Kershaw, E. E. and Flier, J. S. (2004) Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab., 89, 2548-2556.
11. Saye, J. A.; Ragsdale, N. V.; Carey, R. M. and Peach, M. J. (1993) Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes. Am. J. Physiol., 264, C1570-C1576.
12. Boschmann, M.; Kreuzberg, U.; Engeli, S.; Adams, F.; Franke, G.; Klaua, S.; Scholze, J.; Weidinger, G.; Luft, F. C.; Sharma, A. M. and Jordan, J. (2006) The effect of oral glucose loads on tissue metabolism during angiotensin II receptor and beta-receptor blockade in obese hypertensive subjects. Horm. Metab. Res., 38, 323-329.
13. Sugimoto, K.; Qi, N. R.; Kazdova, L.; Pravenec, M.; Ogihara, T. and Kurtz, T. W. (2006) Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis. Hypertension, 47, 1003-1009.
14. Franck, N.; Stenkula, K. G.; Ost, A.; Lindstrom, T.; Stralfors, P. and Nystrom, F. H. (2007) Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual. Diabetologia, 50, 1716-1722.
15. McLaughlin, T.; Sherman, A.; Tsao, P.; Gonzalez, O.; Yee, G.; Lamendola, C.; Reaven, G. M. and Cushman, S. W. (2007) Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipo-genesis. Diabetologia, 50, 1707-1715.
16. Mogi, M.; Iwai, M. and Horiuchi, M. (2006) Emerging concept of adipogenesis regulation by the renin-angiotensin system. Hypertension, 48, 1020-1022.
17. van Harmelen, V.; Elizalde, M.; Ariapart, P.; Bergstedt-Lindqvist, S.; Reynisdottir, S.; Hoffstedt, J.; Lundkvist, I.; Bringman, S. and Arner, P. (2000) The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int. J. Obes. Relat. Metab. Disord., 24, 673-678.
18. Janke, J.; Engeli, S.; Gorzelniak, K.; Luft, F. C. and Sharma, A. M. (2002) Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes, 51, 1699-1707.
19. Darimont, C.; Vassaux, G.; Ailhaud, G. and Negrel, R. (1994) Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology, 135, 2030-2036.
20. Jones, B. H.; Standridge, M. K. and Moustaid, N. (1997) Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology, 138, 1512-1519.
21. Engeli, S.; Bohnke, J.; Gorzelniak, K.; Janke, J.; Schling, P.; Bader, M.; Luft, F. C. and Sharma, A. M. (2005) Weight loss and the renin-angiotensin-aldosterone system. Hypertension, 45, 356-362.
22. Cassis, L. A.; Huang, J.; Gong, M. C. and Daugherty, A. (2004) Role of metabolism and receptor responsiveness in the attenuated responses to Angiotensin II in mice compared to rats. Regul. Pept., 117, 107-116.
23. Massiera, F.; Bloch-Faure, M.; Ceiler, D.; Murakami, K.; Fukamizu, A.; Gasc, J. M.; Quignard-Boulange, A.; Negrel, R.; Ailhaud, G.; Seydoux, J.; Meneton, P. and Teboul, M. (2001) Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB. J., 15, 2727-2729.
24. Massiera, F.; Seydoux, J.; Geloen, A.; Quignard-Boulange, A.; Turban, S.; Saint-Marc, P.; Fukamizu, A.; Negrel, R.; Ailhaud, G. and Teboul, M. (2001) Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology, 142, 5220-5225.
25. Jayasooriya, A. P.; Mathai, M. L.; Walker, L. L.; Begg, D. P.; Denton, D. A.; Cameron-Smith, D.; Egan, G. F.; McKinley, M. J.; Rodger, P. D.; Sinclair, A. J.; Wark, J. D.; Weisinger, H. S.; Jois, M. and Weisinger, R. S. (2008) Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc. Natl. Acad. Sci. USA, 105, 6531-6536.
26. Takahashi, N.; Li, F.; Hua, K.; Deng, J.; Wang, C. H.; Bowers, R. R.; Bartness, T. J.; Kim, H. S. and Harp, J. B. (2007) Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell. Metab., 6, 506-512.
27. Weisinger, R. S.; Stanley, T. K.; Begg, D. P.; Weisinger, H. S.; Spark, K. J. and Jois, M. (2009) Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. Physiol. Behav., 98, 192-197.
28. Santos, S. H.; Fernandes, L. R.; Mario, E. G.; Ferreira, A. V.; Porto, L. C.; Alvarez-Leite, J. I.; Botion, L. M.; Bader, M.; Alenina, N. and Santos, R. A. (2008) Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes, 57, 340-347.
29. Boschmann, M.; Ringel, J.; Klaus, S. and Sharma, A. M. (2001) Metabolic and hemodynamic response of adipose tissue to angiotensin II. Obes. Res., 9, 486-491.
30. Mullen, K. L. Pritchard, J. Ritchie, I. Snook, L. A. Chabowski, A. Bonen, A Wright D and Dyck, D. J. (2009) Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 296, R243-R251.
31. Araki, K.; Masaki, T.; Katsuragi, I.; Tanaka, K.; Kakuma, T. and Yoshimatsu, H. (2006) Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension, 48, 51-57.
32. Zorad, S.; Dou, J. T.; Benicky, J.; Hutanu, D.; Tybitanclova, K.; Zhou, J. and Saavedra, J. M. (2006) Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma. Eur. J. Pharmacol., 552, 112-22.
33. Goyenechea, E.; Dolores Parra, M. and Alfredo Martinez, J. (2006) Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms. Br. J. Nutr., 96, 965-972.
34. Mathai, M. L.; Naik, S.; Sinclair, A. J.; Weisinger, H. S. and Weisinger, R. S. (2008) Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats. Int. J. Obes. (Lond)., 32, 1576-1584.
35. Rong, X.; Li, Y.; Ebihara, K.; Zhao, M.; Naowaboot, J.; Kusakabe, T.; Kuwahara, K.; Murray, M. and Nakao, K. (2010) Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice. Diabetologia, [Epub ahead of print].
36. Ohinata, K.; Fujiwara, Y.; Fukumoto, S.; Iwai, M.; Horiuchi, M. and Yoshikawa, M. (2008) Angiotensin II and III suppress food intake via angiotensin AT(2) receptor and prostaglandin EP(4) receptor in mice. FEBS Lett., 582, 773-777.
37. Dahlof, B.; Zanchetti, A.; Diez, J.; Nicholls, M. G.; Yu, C. M.; Barrios, V.; Aurup, P.; Smith, R. D. anad Johansson, M. (2002) Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. J. Hypertens., 20, 1855-1864.
38. Lindholm, L. H.; Persson, M.; Alaupovic, P.; Carlberg, B.; Svensson, A. and Samuelsson, O. (2003) Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study). J. Hypertens., 21, 1563-1574.
39. Dagenais, G. R.; Gerstein, H. C.; Holman, R.; Budaj, A.; Escalante, A.; Hedner, T.; Keltai, M.; Lonn, E.; McFarlane, S.; McQueen, M.; Teo, K.; Sheridan, P.; Bosch, J.; Pogue, J. and Yusuf, S. (2008) Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetes Care, 31, 1007-1014.
40. Shimabukuro, M.; Tanaka, H. and Shimabukuro, T. (2007) Effects of telmisartan on fat distribution in individuals with the metabolic syndrome. J. Hypertens., 25, 841-848.
41. de Luis, D. A.; Conde, R.; Gonzalez-Sagrado, M.; Aller, R.; Izaola, O.; Duenas, A.; Perez Castrillon, J. L. and Romero, E. (2010) Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients. Nutr. Hosp., 25, 275-279.
42. Krysiak, R.; Sierant, M.; Marek, B.; Bienek, R. and Okopien, B. (2010) The effect of angiotensin-converting enzyme inhibitors on plasma adipokine levels in normotensive patients with coronary artery disease. Endokrynol. Pol., 61, 280-287.
43. Delafontaine, P. and Lou, H. (1993) Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. J. Biol. Chem., 268, 16866-16870.
44. Du, J.; Meng, X. P. and Delafontaine, P. (1996) Transcriptional regulation of the insulin-like growth factor-I receptor gene: evidence for protein kinase C-dependent and -independent pathways. Endocrinology, 137, 1378-1384.
45. Brink, M.; Wellen, J. and Delafontaine, P. (1996) Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J. Clin. Invest., 97, 2509-2516.
46. Ketelslegers, J. M.; Maiter, D.; Maes, M.; Underwood, L. E. and Thissen, J. P. 1995) Nutritional regulation of insulin-like growth factor-I. Metabolism, 44, 50-57.
47. Brink, M.; Price, S. R.; Chrast, J.; Bailey, J. L.; Anwar, A.; Mitch, W. E. and Delafontaine, P. (2001) Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down- regulates autocrine insulin-like growth factor I. Endocrinology, 142, 1489-1496.
48. Cassis, L. A.; Marshall, D. E.; Fettinger, M. J.; Rosenbluth, B. and Lodder, R. A. (1998) Mechanisms contributing to angiotensin II regulation of body weight. Am. J. Physiol., 274, E867-E876.
49. Porter, J. P.; Anderson, J. M.; Robison, R. J. and Phillips, A. C. (2003) Effect of central angiotensin II on body weight gain in young rats. Brain Res., 959, 20-28.
50. Porter, J. P. and Potratz, K. R. (2004) Effect of intracerebro-ventricular angiotensin II on body weight and food intake in adult rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 287, R422-R428.
51. Weisinger, R. S.; Denton, D. A.; McKinley, M. J.; Muller, A. F. and Tarjan, E. (1986) Angiotensin and Na appetite of sheep. Am. J. Physiol., 251, R690-R699.
52. Weisinger, R. S. B. P. (1999) Influence of centrally-administered peptides on thirst and sodium appetite. Protein Pept. Lett., 6, 281-294.
53. Cassis, L. A. (1993) Role of angiotensin II in brown adipose thermogenesis during cold acclimation. Am. J. Physiol., 265, E860-E865.
54. Cassis, L. A. and Dwoskin, L. P. (1991) Presynaptic modulation of neurotransmitter release by endogenous angiotensin II in brown adipose tissue. J. Neural. Transm. Suppl., 34, 129-137.
55. Beard, K. M.; Lu, H.; Ho, K. and Fantus, I. G. (2006) Bradykinin augments insulin-stimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of Jun NH2- terminal kinase. Diabetes, 55, 2678-2687.
56. Henriksen, E. J.; Jacob, S.; Kinnick, T. R.; Teachey, M. K. and Krekler, M. (2001) Selective angiotensin II receptor receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension, 38, 884-890.
57. Unger, T. (2001) Pharmacology of AT1-receptor blockers. Blood Press Suppl., 5-10.
58. Csibi, A.; Cornille, K.; Leibovitch, M. P.; Poupon, A.; Tintignac, L. A.; Sanchez, A. M. and Leibovitch, S. A. (2010) The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse. PLoS One 5, e8994.
59. Luft, F. (2010) The renin, angiotensin, aldosterone, and obesity connection. J. Mol. Med., 88, 861-864.
60. Hilzendeger, A. M.; Morais, R. L.; Todiras, M.; Plehm, R.; da Costa Goncalves, A.; Qadri, F.; Araujo, R. C.; Gross, V.; Nakaie, C. R.; Casarini, D. E.; Carmona, A. K.; Bader, M. and Pesquero, J. B. (2010) Leptin regulates ACE activity in mice. J. Mol. Med., 88, 899-907.
61. Janovska, A.; Hatzinikolas, G.; Staikopoulos, V.; McInerney, J.; Mano, M. and Wittert, G. A. (2008) AMPK and ACC phosphoryla- tion: effect of leptin, muscle fibre type and obesity. Mol. Cell Endocrinol., 284, 1-10.
62. Akasaka, Y.; Tsunoda, M.; Ogata, T.; Ide, T. and Murakami, K. (2010) Direct evidence for leptin-induced lipid oxidation independent of long-form leptin receptor. Biochim. Biophys. Acta., 1801, 1115-1122.
63. Donahoo, W. T.; Stob, N. R.; Ammon, S.; Levin, N. and Eckel, R. H. (2010) Leptin increases skeletal muscle lipoprotein lipase and postprandial lipid metabolism in mice. Metabolism, 60, 438-443.
64. Mitterberger, M. C.; Mattesich, M.; Klaver, E.; Lechner, S.; Engelhardt, T.; Larcher, L.; Pierer, G.; Piza-Katzer, H. and Zwerschke, W. (2010) Adipokine profile and insulin sensitivity in formerly obese women subjected to bariatric surgery or diet-induced long-term caloric restriction. J. Gerontol. A. Biol. Sci. Med. Sci., 65, 915-923.
65. Banks, A. S.; Davis, S. M.; Bates, S. H. and Myers, M. G. Jr. (2000) Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem., 275, 14563-14572.
66. Bates, S. H.; Stearns, W. H.; Dundon, T. A.; Schubert, M.; Tso, A. W.; Wang, Y.; Banks, A. S.; Lavery, H. J.; Haq, A. K.; Maratos- Flier, E.; Neel, B. G.; Schwartz, M. W. and Myers, M. G. Jr. (2003) STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature, 421, 856-859.
67. Bjorbak, C.; Lavery, H. J.; Bates, S. H.; Olson, R. K.; Davis, S. M.; Flier, J. S. and Myers, M. G. Jr, (2000) SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem., 275, 40649-40657.
68. Dunn, S. L.; Bjornholm, M.; Bates, S. H.; Chen, Z.; Seifert, M. and Myers, M. G.Jr., (2005) Feedback inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of cytokine signaling 3. Mol. Endocrinol., 19, 925-938.
69. Knobelspies, H.; Zeidler, J.; Hekerman, P.; Bamberg-Lemper, S. and Becker, W. (2010) Mechanism of attenuation of leptin signaling under chronic ligand stimulation. BMC Biochem., 11, 2.
70. Bence, K. K.; Delibegovic, M.; Xue, B.; Gorgun, C. Z.; Hotamisligil, G. S.; Neel, B. G. and Kahn, B. B. (2006) Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat. Med., 12, 917-924.
71. Ketsawatsomkron, P.; Stepp, D. W.; Fulton, D. J. and Marrero, M. B. (2010) Molecular mechanism of angiotensin II-induced insulin resistance in aortic vascular smooth muscle cells: roles of Protein Tyrosine Phosphatase-1B. Vascul. Pharmacol., 53, 160-168.
72. White, C. L.; Whittington, A.; Barnes, M. J.; Wang, Z.; Bray, G. A. and Morrison, C. D. (2009) HF diets increase hypothalamic PTP1B and induce leptin resistance through both leptin-dependent and - independent mechanisms. Am. J. Physiol. Endocrinol. Metab., 296, E291-E299.
73. Picardi, P. K.; Calegari, V. C.; Prada Pde, O.; Moraes, J. C.; Araujo, E.; Marcondes, M. C.; Ueno, M.; Carvalheira, J. B.; Velloso, L. A. and Saad, M. J. (2008) Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese rats. Endocrinology, 149, 3870-3880.
74. Santos, E. L.; de Picoli Souza, K.; Guimaraes, P. B.; Reis, F. C.; Silva, S. M.; Costa-Neto, C. M.; Luz, J. and Pesquero, J. B. (2008) Effect of angiotensin converting enzyme inhibitor enalapril on body weight and composition in young rats. Int. Immunopharmacol., 8, 247-253.
75. Carter, C. S.; Onder, G.; Kritchevsky, S. B. and Pahor, M. (2005) Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance. J. Gerontol. A. Biol. Sci. Med. Sci., 60, 1437-1446.
76. Zanchi, A.; Dulloo, A. G.; Perregaux, C.; Montani, J. P. and Burnier, M. (2007) Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties. Am. J. Physiol. Endocrinol. Metab., 293, E91-E95.
77. Sugimoto, K.; Kazdova, L.; Qi, N. R.; Hyakukoku, M.; Kren, V.; Simakova, M.; Zidek, V.; Kurtz, T. W. and Pravenec, M. (2008) Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway. J. Hypertens., 26, 1209-1215.
78. Cole, B. K.; Keller, S. R.; Wu, R.; Carter, J. D.; Nadler, J. L. and Nunemaker, C. S. Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice. Hypertension, 55, 715-721.
79. Stucchi, P.; Cano, V.; Ruiz-Gayo, M. and Fernandez-Alfonso, M. S. (2009) Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity. Br. J. Pharmacol., 158, 771-778.
80. Boschmann, M.; Engeli, S.; Adams, F.; Franke, G.; Luft, F. C.; Sharma, A. M. and Jordan, J. (2006) Influences of AT1 receptor blockade on tissue metabolism in obese men. Am. J. Physiol. Regul. Integr. Comp. Physiol., 290, R219-R223.
81. Masuo, K.; Mikami, H.; Ogihara, T. and Tuck, M. L. (2001) Weight reduction and pharmacologic treatment in obese hyper-tensives. Am. J. Hypertens., 14, 530-538.
82. No authors listed (1984) Enalapril in essential hypertension: a comparative study with propranolol. Enalapril in Hypertension Study Group (UK). Br. J. Clin. Pharmacol., 18, 51-56.